Steatohepatitis is a medical term that refers to a type of liver disease characterized by inflammation and fatty infiltration of the liver. The condition can be broadly categorized into two types, namely alcoholic steatohepatitis (ASH) and non-alcoholic steatohepatitis (NASH), depending on the underlying cause.
When excessive alcohol consumption is the leading factor, it results in alcoholic steatohepatitis. This condition is often associated with alcohol abuse and has similar symptoms to alcoholic hepatitis, including liver inflammation and damage. Over time, if left untreated, ASH can progress to more severe liver conditions such as cirrhosis or liver failure.
On the other hand, non-alcoholic steatohepatitis occurs in individuals who exhibit similar liver inflammation and fat accumulation but are not heavy alcohol users. Instead, various factors contribute to NASH, including obesity, insulin resistance, diabetes, high cholesterol levels, and metabolic syndrome. Unlike ASH, NASH is more prevalent in individuals with underlying health conditions or those with a diet rich in high-calorie and fatty foods.
The symptoms of steatohepatitis may include fatigue, abdominal discomfort, jaundice, loss of appetite, weight loss, and confusion. Diagnosis typically involves blood tests, imaging studies such as ultrasound or CT scan, and sometimes a liver biopsy to confirm the presence of inflammation and fat accumulation.
Treatment for steatohepatitis typically focuses on managing the underlying cause. This may involve lifestyle modifications such as weight loss, regular exercise, adopting a healthy diet, and avoiding alcohol consumption. In more severe cases, medications may be prescribed to manage specific symptoms or complications. Regular monitoring through follow-up appointments and periodic liver function tests is crucial to assess the progress of the condition and prevent further liver damage.
